thisdrug what a medicine's name tells you

WHO naming stem · suffix · 30 listed names

-tant

This page was written with AI.

neurokinin (tachykinin) receptor antagonists

WHO's definition, quoted as written in the 2024 stem book

8 of 30 names appear in these lists: 8 in the US list (FDA Drugs@FDA) and 6 in the EU central list (EMA); 4 have national brands in at least one EU/EEA country.

Names only. This page is about -tant as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -tant. So the letters tant sit at the end of the name (…tant).

All 30 names WHO lists under -tant

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 8 of 30 names appear in these lists: 8 in the US list (FDA Drugs@FDA) and 6 in the EU central list (EMA); 4 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.

  1. aprepitant
    US brands: APONVIE, CINVANTI, EMEND
    EU (central) brands: Emend
  2. befetupitant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  3. burapitant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  4. casopitant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  5. dapitant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  6. elinzanetant
    US brands: LYNKUET
    EU (central) brands: Lynkuet
  7. ezlopitant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  8. fezolinetant
    US brands: VEOZAH
    EU (central) brands: Veoza
  9. figopitant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  10. fosaprepitant
    US brands: EMEND, FOCINVEZ, NAVITRUX
    EU (central) brands: Ivemend
  11. fosnetupitant
    US brands, in combination: AKYNZEO with palonosetron
    EU (central) brands: none found
  12. ibodutant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  13. imnopitant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  14. lanepitant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  15. maropitant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  16. meclinertant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  17. nepadutant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  18. netupitant
    US brands, in combination: AKYNZEO with palonosetron
    EU (central) brands, in combination: Akynzeo with palonosetron
  19. orvepitant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  20. osanetant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  21. pavinetant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  22. reminertant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  23. rolapitant
    US brands: VARUBI
    EU (central) brands: Varuby (withdrawn)
  24. saredutant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  25. serlopitant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  26. talnetant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  27. telmapitant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  28. tradipitant
    US brands: NEREUS
    EU (central) brands: none found
  29. vestipitant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  30. vofopitant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)

US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.

EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.

EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.

Decode another name

Decoded

dapitant

Listed INNCarries 2 WHO stems, most specific first: -pitant …

  • -pitantend of the nameWHO lists it hereWHO definition: neurokinin NK1 (substance P) receptor antagonist
  • -tantend of the nameWHO lists it hereWHO definition: neurokinin (tachykinin) receptor antagonists

“dapitant” is an INN that WHO lists under -pitant, -tant in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -tant (Part II B) and the 30 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.

Made with AI tools. · Privacy